New BC Platforms Partnership with Artisan Biomed to Unlock African Access to Precision Medicine

Alfa Chemistry Announces to Supply MOF Materials for the Science Community

BOC RNA’s GMP Oligonucleotide Facility Ready to Roll for Clinical Application

Bio-Rad Launches the SEQuoia RiboDepletion Kit for Next-Generation Sequencing

Qvella Appoints Richard Brock as VP of Global Marketing and Signals Start of Commercialization

Qvella, a diagnostics company that aims to reduce the time to results in the diagnosis of infections, today announced that it has appointed Richard Brock as VP of Global Marketing. In this role, he will lead the imminent commercialization of Qvella’s FAST-Prep™ product for Positive Blood Culture (PBC) processing.

Geisinger Health Plan Makes Searching for a Provider Easier with Kyruus-HealthSparq Integration

Accurics Completes SOC 2 Type 1 Certification

Bally Ribbon Mills Innovates with New Series of Advanced Textile Products for Electronic Transmission Data, Manufacturing Automation, and Industrial Design

Bally Ribbon Mills Innovates with New Series of Advanced Textile Products for Electronic Transmission Data, Manufacturing Automation, and Industrial Design. Offering advanced woven webbing used in parachutes, safety harnesses, and protective equipment

Alveo Technologies Appoints Veteran Biotech and Diagnostics Leader to Board of Directors

Alveo Technologies Appoints Veteran Biotech and Diagnostics Leader to Board of Directors

THREAD Launches Industry-First Analytics Solution for Decentralized Clinical Trials (DCTs)

The new Thread analytics dashboard provides researchers with real-time, actionable insights to reduce risk, automate oversight and improve outcomes.

New Certa Plus Sinusoidal Pump

A best in class, sustainable solution for shear sensitive, viscous pharmaceutical products

FDS Amplicare and Mutual Drug Offers Analytics Solution to Member Pharmacies

FDS Amplicare and Mutual Drug Offers Analytics Solution to Member Pharmacies

Antibiotic Research UK announces winners of ‘Bio-Baddie’ competition

Antibiotic Research UK (ANTRUK), the world’s first publicly funded charity focused solely on tackling the global threat of drug-resistant infections, is delighted to announce the winners of the 2021 Bio-Baddie art competition. The competition encouraged participants of any age to draw what they think an antibiotic resistant bacteria might look like as part of British Science Week 2021. We would like to congratulate the winners Atharv, Gruffydd, Sindija and Samrin.

CD ComputaBio Releases Excited State Computing Service for Basic Research

In a recent statement, CD ComputaBio says that the excited state computing service is already available to all customers.

FAST BioMedical Announces Successful Completion of Open-Label Proof-of-Concept Study for Measuring Interstitial Volume

FAST BioMedical, a privately held, late-clinical-stage medical technology company, today announces the completion of an open-label study using its technology in chronic dialysis patients.

Sensyne Health Signs First US Strategic Research Agreement with St. Luke’s University Health Network

Sensyne Health Signs First US Strategic Research Agreement with St. Luke’s University Health Network

MicrobioSeq Introduces Microbial Iso-Seq to Characterize the Diverse Landscape of Transcript Isoforms

Bioinformatics-Analysis Division of CD Genomics Introduces Single Cell Genome Analysis Services

Rousselot® Biomedical launches X-Pure® GelDAT, first ever purified and phenol-functionalized gelatin

Rousselot®, a brand of Darling Ingredients, and the global leader of collagen-based solutions1 expands its range of purified, pharmaceutical grade, modified gelatins with the launch of X-Pure® GelDAT – Gelatin Desaminotyrosine. Created in response to customers' demands to overcome the barriers encountered in clinic translation, this is the first readily available biomaterial of its kind. X-Pure® GelDAT offers guaranteed purity and consistency at scale, vital to the successful development of biomedical applications used in the human body.

Sharp Appoints New Leader to its Global Clinical Services Business